Literature DB >> 19843551

Coronary revascularization in a child with homozygous familial hypercholesterolemia.

Mohammad Hassan Nemati1.   

Abstract

Familial hypercholesterolemia (FH) is a genetic disease caused by a mutation in low-density lipoprotein (LDL) receptor gene. It causes various presentations including tendon xanthoma and cardiac manifestations. Herein, we present a young patient with homozygous FH (HFH) who presented with dyspnea and chest pain caused by coronary arteries stenosis and treated with coronary artery bypass graft (CABG) surgery at the age of 13 years. To the best of our knowledge, he is one of the youngest patients in the English language literature for whom coronary revascularization has been done in childhood.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19843551     DOI: 10.1510/icvts.2009.217513

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  4 in total

Review 1.  Optimal management of familial hypercholesterolemia: treatment and management strategies.

Authors:  Mohammad Hassan Nemati; Behrooz Astaneh
Journal:  Vasc Health Risk Manag       Date:  2010-12-03

2.  Redux valvular surgery with coronary artery bypass graft in familial hypercholesterolemia.

Authors:  Ziadi Jalel; Mleyhi Sobhi; Ben Omrane Skander; Khayati Adel
Journal:  Ann Pediatr Cardiol       Date:  2014-01

3.  The Genetic Spectrum of Familial Hypercholesterolemia (FH) in the Iranian Population.

Authors:  R H Fairoozy; M Futema; R Vakili; M R Abbaszadegan; S Hosseini; M Aminzadeh; H Zaeri; M Mobini; S E Humphries; A Sahebkar
Journal:  Sci Rep       Date:  2017-12-06       Impact factor: 4.379

Review 4.  State-of-the-Art Pediatric Coronary Artery Bypass Surgery: a Literature Review.

Authors:  Roman Komarov; Alisher Ismailbaev; Vagi Chragyan; Bakytbek Kadyraliev; Michel Pompeu B O Sá; Arjang Ruhparwar; Alexander Weymann; Konstantin Zhigalov
Journal:  Braz J Cardiovasc Surg       Date:  2020-08-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.